We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Head and Neck Cancer Treatment in 45 Years
FDA Approves First Head and Neck Cancer Treatment in 45 Years
March 8, 2006
The FDA approved Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery.